MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
BDTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Black Diamond Therapeutics (BDTX) Ownership - Who owns Black Diamond Therapeutics?

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
245 First Street
Phone
+1 617 252-0848
Employees
21
Web
https://www.blackdiamondtherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
92.54M
P/E Ratio
7.33
Total Cash
118.26M
Projected Growth
N/A
Total Debt
17.88M
Revenue
N/A
Risk (Beta)
4.38
Dividend Yield
N/A
Total Cash/Share
2.06
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
BDTX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for BDTX
A.I. Advisor
published General Information

General Information

a biotechnology company that discovers and develops therapeutic agents to target unique oncogenic protein-isoforms.

Industry Biotechnology

Profile
Details
Industry
N/A
Address
245 First Street
Phone
+1 617 252-0848
Employees
21
Web
https://www.blackdiamondtherapeutics.com